Učitavanje...
Predicting the clinical course of prostate cancer
Risk stratification in prostate cancer remains a significant clinical challenge. A study in this issue of the JCI describes an exciting application of high-throughput functional genomic technology to further refine our understanding of treatment failure risk in prostate cancer patients .
Spremljeno u:
| Izdano u: | J Clin Invest |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society for Clinical Investigation
2004
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC362125/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15067311/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI21310 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|